• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种疫苗后仍有传染性 SARS-CoV-2 的脱落。

Shedding of infectious SARS-CoV-2 despite vaccination.

机构信息

Department of Pathobiological Sciences, University of Wisconsin School of Veterinary Medicine, Madison, Wisconsin, United States of America.

Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.

出版信息

PLoS Pathog. 2022 Sep 30;18(9):e1010876. doi: 10.1371/journal.ppat.1010876. eCollection 2022 Sep.

DOI:10.1371/journal.ppat.1010876
PMID:36178969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9555632/
Abstract

The SARS-CoV-2 Delta Variant of Concern is highly transmissible and contains mutations that confer partial immune escape. The emergence of Delta in North America caused the first surge in COVID-19 cases after SARS-CoV-2 vaccines became widely available. To determine whether individuals infected despite vaccination might be capable of transmitting SARS-CoV-2, we compared RT-PCR cycle threshold (Ct) data from 20,431 test-positive anterior nasal swab specimens from fully vaccinated (n = 9,347) or unvaccinated (n = 11,084) individuals tested at a single commercial laboratory during the interval 28 June- 1 December 2021 when Delta variants were predominant. We observed no significant effect of vaccine status alone on Ct value, nor when controlling for vaccine product or sex. Testing a subset of low-Ct (<25) samples, we detected infectious virus at similar rates, and at similar titers, in specimens from vaccinated and unvaccinated individuals. These data indicate that vaccinated individuals infected with Delta variants are capable of shedding infectious SARS-CoV-2 and could play a role in spreading COVID-19.

摘要

令人关注的 SARS-CoV-2 德尔塔变异株具有高度传染性,并包含部分免疫逃逸的突变。德尔塔在北美出现,导致 COVID-19 病例在 SARS-CoV-2 疫苗广泛使用后首次激增。为了确定接种疫苗后仍被感染的个体是否能够传播 SARS-CoV-2,我们比较了在一家商业实验室在 2021 年 6 月 28 日至 12 月 1 日期间进行的 20,431 例前鼻拭子阳性标本的 RT-PCR 循环阈值 (Ct) 数据,这些标本来自完全接种疫苗的个体(n = 9,347)或未接种疫苗的个体(n = 11,084)。我们发现疫苗接种状态本身对 Ct 值没有显著影响,也没有控制疫苗产品或性别。在对低 Ct 值(<25)样本进行测试时,我们在接种疫苗和未接种疫苗个体的标本中以相似的速率和相似的滴度检测到传染性病毒。这些数据表明,感染德尔塔变异株的接种疫苗个体能够释放具有传染性的 SARS-CoV-2,并且可能在传播 COVID-19 方面发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b51e/9555632/d7b986305a53/ppat.1010876.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b51e/9555632/d7b986305a53/ppat.1010876.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b51e/9555632/d7b986305a53/ppat.1010876.g001.jpg

相似文献

1
Shedding of infectious SARS-CoV-2 despite vaccination.接种疫苗后仍有传染性 SARS-CoV-2 的脱落。
PLoS Pathog. 2022 Sep 30;18(9):e1010876. doi: 10.1371/journal.ppat.1010876. eCollection 2022 Sep.
2
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株德尔塔迅速被奥密克戎取代:新冠病毒疾病病例数出现前所未有的激增,住院人数减少,上呼吸道病毒载量相当。
medRxiv. 2022 Jan 28:2022.01.26.22269927. doi: 10.1101/2022.01.26.22269927.
3
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.与未接种疫苗的患者相比,使用主要生物标志物比较感染 SARS-CoV-2 Delta 或 Omicron VOC 患者的疾病严重程度和同源疫苗接种效果。
J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9.
4
Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.接种疫苗和未接种疫苗个体中的 SARS-CoV-2 传播和传染性脱落动力学。
JAMA Netw Open. 2022 May 2;5(5):e2213606. doi: 10.1001/jamanetworkopen.2022.13606.
5
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日,加利福尼亚州洛杉矶县≥16 岁人群中,根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
6
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.英国未接种和接种疫苗人群中 SARS-CoV-2 德尔塔(B.1.617.2)变异株的社区传播和病毒载量动力学:一项前瞻性、纵向、队列研究。
Lancet Infect Dis. 2022 Feb;22(2):183-195. doi: 10.1016/S1473-3099(21)00648-4. Epub 2021 Oct 29.
7
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州,2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
8
Determining the impact of vaccination on SARS-CoV-2 RT-PCR cycle threshold values and infectious viral titres.确定疫苗接种对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)逆转录聚合酶链反应(RT-PCR)循环阈值和传染性病毒滴度的影响。
Access Microbiol. 2023 Oct 20;5(10). doi: 10.1099/acmi.0.000597.v3. eCollection 2023.
9
Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey.新泽西州一家大型医疗机构中接种和未接种人群中 SARS-CoV-2 感染的分子和临床流行病学研究。
Viruses. 2023 Aug 5;15(8):1699. doi: 10.3390/v15081699.
10
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.SARS-CoV-2 变异株特异性复制 RNA 疫苗可预防同源关切变异株挑战后的疾病。
Elife. 2022 Feb 22;11:e75537. doi: 10.7554/eLife.75537.

引用本文的文献

1
Prognostic Impact of Vaccination, Comorbidity, and Inflammatory Biomarkers on Clinical Outcome in Hospitalized Patients with COVID-19.疫苗接种、合并症和炎症生物标志物对COVID-19住院患者临床结局的预后影响
Biomedicines. 2025 Aug 16;13(8):1995. doi: 10.3390/biomedicines13081995.
2
The effect of COVID-19 vaccination on viral load among health care workers: a retrospective cohort study.新冠病毒疫苗接种对医护人员病毒载量的影响:一项回顾性队列研究。
Clin Exp Vaccine Res. 2025 Jul;14(3):261-266. doi: 10.7774/cevr.2025.14.e24. Epub 2025 May 21.
3
Significant Increase in Excess Deaths after Repeated COVID-19 Vaccination in Japan.

本文引用的文献

1
Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case-case study based on electronic health records.基于电子健康记录的病例对照研究:比较 COVID-19 疫苗在预防 SARS-CoV-2 奥密克戎(BA.1)和德尔塔(B.1.617.2)变异株感染方面的完整方案和加强针效果。
Influenza Other Respir Viruses. 2023 Mar 14;17(3):e13121. doi: 10.1111/irv.13121. eCollection 2023 Mar.
2
Impact of COVID-19 vaccination on transmission risk of breakthrough infections: Lessons from adapted N95 mask sampling for emerging variants and interventions.新冠病毒疫苗接种对突破性感染传播风险的影响:从针对新兴变异株和干预措施的适应性 N95 口罩采样中获得的经验教训。
J Med Virol. 2023 Jan;95(1):e28188. doi: 10.1002/jmv.28188. Epub 2022 Oct 12.
3
日本重复接种新冠疫苗后超额死亡人数显著增加。
JMA J. 2025 Apr 28;8(2):584-586. doi: 10.31662/jmaj.2024-0298. Epub 2025 Mar 7.
4
The Effect of Preexisting Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Infection Outcomes in Exposed Household Members.既往冠状病毒抗体对暴露家庭成员中严重急性呼吸综合征冠状病毒2感染结局的影响。
J Infect Dis. 2025 Aug 14;232(2):e318-e326. doi: 10.1093/infdis/jiaf172.
5
Post-exposure testing at healthcare facilities with SARS-CoV-2 transmission: A rapid review.医疗机构中SARS-CoV-2传播后的暴露后检测:一项快速综述。
J Public Health Afr. 2025 Feb 23;16(2):623. doi: 10.4102/jphia.v16i2.623. eCollection 2025.
6
Time-varying effects of COVID-19 vaccination on symptomatic and asymptomatic infections in a prospective university cohort in the USA.美国一所大学前瞻性队列研究中COVID-19疫苗接种对有症状和无症状感染的时变效应。
BMJ Open. 2025 Feb 22;15(2):e084408. doi: 10.1136/bmjopen-2024-084408.
7
Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters.佐剂亚单位鼻内疫苗可降低仓鼠体内严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的传播。
Front Immunol. 2025 Feb 7;16:1514845. doi: 10.3389/fimmu.2025.1514845. eCollection 2025.
8
COVID-19 clinical presentation, management, and epidemiology: a concise compendium.新型冠状病毒肺炎的临床表现、治疗与流行病学:简明概要
Front Public Health. 2025 Jan 31;13:1498445. doi: 10.3389/fpubh.2025.1498445. eCollection 2025.
9
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial.NVX-CoV2373在美国青少年中预防新型冠状病毒2型感染的疫苗效力:一项3期、观察者盲法、随机、安慰剂对照试验的辅助研究
Lancet Microbe. 2025 Apr;6(4):100984. doi: 10.1016/j.lanmic.2024.100984. Epub 2025 Jan 27.
10
Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies.纳米抗体筛选及机器学习辅助鉴定针对新冠病毒变异株的仅重链抗SARS-CoV-2中和抗体
PLoS Pathog. 2025 Jan 23;21(1):e1012903. doi: 10.1371/journal.ppat.1012903. eCollection 2025 Jan.
Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine-Induced Immunity in Older Adults.衰弱、年龄和生物性别与老年人严重急性呼吸综合征冠状病毒 2 信使 RNA 疫苗诱导免疫的关系。
Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S61-S71. doi: 10.1093/cid/ciac397.
4
Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness.每日纵向采样 SARS-CoV-2 感染揭示了传染性的显著异质性。
Nat Microbiol. 2022 May;7(5):640-652. doi: 10.1038/s41564-022-01105-z. Epub 2022 Apr 28.
5
Risk factors for severe COVID-19 differ by age for hospitalized adults.住院成年人中,严重 COVID-19 的风险因素因年龄而异。
Sci Rep. 2022 Apr 28;12(1):6568. doi: 10.1038/s41598-022-10344-3.
6
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case-control study.美国大型医疗体系中,针对奥密克戎和德尔塔变异株,BNT162b2 疫苗对住院和急诊科就诊的持久性:一项病例对照研究。
Lancet Respir Med. 2022 Jul;10(7):689-699. doi: 10.1016/S2213-2600(22)00101-1. Epub 2022 Apr 22.
7
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination.在撒丁岛队列组中,BNT162b2疫苗接种后长达9个月针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的中和抗体反应
Vaccines (Basel). 2022 Mar 29;10(4):531. doi: 10.3390/vaccines10040531.
8
Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children.SARS-CoV-2 mRNA疫苗在青少年中的持久性和交叉反应性
Vaccines (Basel). 2022 Mar 23;10(4):492. doi: 10.3390/vaccines10040492.
9
Comparison between nucleic acid amplification tests, antigen immunofluorescence assay, and in vitro infectivity in SARS-CoV-2 diagnosis.核酸扩增检测、抗原免疫荧光分析与体外感染性在 SARS-CoV-2 诊断中的比较。
Braz J Microbiol. 2022 Sep;53(3):1271-1277. doi: 10.1007/s42770-022-00758-6. Epub 2022 Apr 21.
10
Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors.2型糖尿病患者感染新型冠状病毒2后死亡情况:潜在危险因素的人群水平分析
Diabetes Ther. 2022 May;13(5):1037-1051. doi: 10.1007/s13300-022-01259-3. Epub 2022 Apr 13.